Sequential Tocilizumab and Tofacitinib Treatment for Systemic Juvenile Idiopathic Arthritis: a Case Report

Systemic juvenile idiopathic arthritis (sJIA) is a complex and difficult to cure condition with high disability and mortality rates. Herein, we report the case of a patient with sJIA who was treated with sequential tocilizumab (TCZ) and tofacitinib treatment. The patient was a 4-year-old girl hospit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ye, Ru, Jinli, Zhang, Jinxiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931954/
https://www.ncbi.nlm.nih.gov/pubmed/36443570
http://dx.doi.org/10.1007/s40744-022-00496-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931954/
https://www.ncbi.nlm.nih.gov/pubmed/36443570
http://dx.doi.org/10.1007/s40744-022-00496-z

Ejemplares similares